45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
15,681
Insurances with rates
7
CPT / HCPCS codes
11,675
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 41096 | PACLITAXEL-PROTEIN BOUND 100 MG IV SOLR | $436,097 | $305,268 | — | — | 0 |
| 48729 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML IVES SUSP | $87,000 | $60,900 | — | — | 0 |
| 48105 | GLOFITAMAB-GXBM 1 MG/ML IV SOLN (>10 MG DOSE 10 ML MIXTURE COMPONENT) | $84,614 | $59,230 | — | — | 0 |
| 47433 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20 ML IV SOLN | $75,593 | $52,915 | — | — | 0 |
| 36101047 | HC INSERT/REPLACE PERPH SACRAL/GSTR NEUROSTIM PULSE GEN/RCVR PCKT CREATE & CONNECT ELECTRODE/PULSE G | $72,159 | $50,511 | — | — | 0 |
| 36100811 | HC INSERTION/REPLACEMENT SPINAL NEUROSTIMULATOR PULSE GENERATOR/RECEIVER DIRECT/INDUCTIVE COUPLING | $66,554 | $46,588 | — | — | 0 |
| 43219 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $62,876 | $44,013 | — | — | 0 |
| 46784 | DOSTARLIMAB-GXLY 50 MG/ML IV SOLN | $61,350 | $42,945 | — | — | 0 |
| 31000102 | HC BRCA1 BRCA2 GENE ANALYSIS FULL SEQ ANALYSIS & FULL DUPLICATION/DELETION ANALYSIS | $57,748 | $40,424 | — | — | 0 |
| 49107 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $49,327 | $34,529 | — | — | 0 |
| 34032 | YTTRIUM-90 (SIR-SPHERES) MICROSPHERES | $43,468 | $30,428 | — | — | 0 |
| 49118 | TARLATAMAB-DLLE 10 MG IV SOLR | $41,400 | $28,980 | — | — | 0 |
| 48723 | TARLATAMAB-DLLE 10 MG IV SOLR | $41,381 | $28,967 | — | — | 0 |
| 49119 | IMETELSTAT 188 MG IV SOLR | $38,047 | $26,633 | — | — | 0 |
| 35979 | POLATUZUMAB VEDOTIN-PIIQ 20 MG/ML IV WET SOLR VIAL (RECON 140 MG VIAL) | $37,260 | $26,082 | — | — | 0 |
| 31590 | LURBINECTEDIN 4 MG IV SOLR | $36,615 | $25,631 | — | — | 0 |
| 31766 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) IV SOLN | $35,526 | $24,868 | — | — | 0 |
| 44221 | PERTUZUMAB-TRASTUZUMAB-HY-ZZXF 1,200 MG-600MG- 30000 UNIT/15ML SUBQ SOLN | $35,072 | $24,550 | — | — | 0 |
| 25339 | EMICIZUMAB-KXWH 105 MG/0.7 ML SUBQ SOLN | $35,039 | $24,527 | — | — | 0 |
| 35787 | AMIVANTAMAB-VMJW 50 MG/ML IV SOLN | $32,941 | $23,059 | — | — | 0 |
| 22762 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) IV SOLN | $30,221 | $21,155 | — | — | 0 |
| 33152 | TESTOSTERONE 75 MG IMPL PLLT | $29,210 | $20,447 | — | — | 0 |
| 25073 | DURVALUMAB 50 MG/ML IV SOLN | $28,805 | $20,164 | — | — | 0 |
| 36564 | LUSPATERCEPT-AAMT 75 MG SUBQ SOLR | $28,494 | $19,946 | — | — | 0 |
| 36101058 | HC REVISION INCL REPLACEMENT SPINAL NEUROSTIMULATOR ELECTRODE PLATE/PADDLE(S) LAMINOTOMY/LAMINECTOMY | $27,109 | $18,976 | — | — | 0 |
| 46427 | TREMELIMUMAB-ACTL 20 MG/ML IV SOLN | $26,910 | $18,837 | — | — | 0 |
| 49404 | ZOLBETUXIMAB-CLZB 300 MG IV SOLR (WET SOLR VIAL) | $26,496 | $18,547 | — | — | 0 |
| 49225 | TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) IV SOLN | $25,650 | $17,955 | — | — | 0 |
| 38133 | CEMIPLIMAB-RWLC 50 MG/ML IV SOLN | $25,491 | $17,844 | — | — | 0 |
| 39886 | SACITUZUMAB GOVITECAN-HZIY 180 MG IV SOLR | $25,174 | $17,622 | — | — | 0 |
| 41099 | PEMBROLIZUMAB 100 MG/4 ML (25 MG/ML) IV SOLN | $24,182 | $16,927 | — | — | 0 |
| 36000039 | HC OR ACUITY 5 | $23,269 | $16,288 | — | — | 0 |
| 31881 | BEVACIZUMAB-AWWB 25 MG/ML IV SOLN | $23,109 | $16,176 | — | — | 0 |
| 49775 | TISLELIZUMAB-JSGR 10 MG/ML IV SOLN | $23,077 | $16,154 | — | — | 0 |
| 36101043 | HC PERCUTANEOUS IMPLANTATION OF NEUROSTIMULATOR ELECTRODE ARRAY PERIPHERAL NERVE | $23,006 | $16,104 | — | — | 0 |
| 31562 | DARATUMUMAB-HYALURONIDASE-FIHJ 1,800 MG-30,000 UNIT/15 ML SUBQ SOLN | $20,905 | $14,634 | — | — | 0 |
| 39588 | BEVACIZUMAB-BVZR 25 MG/ML IV SOLN | $20,316 | $14,221 | — | — | 0 |
| 36101012 | HC PERCUTANEOUS IMPLANTATION OF NEUROSTIMULATOR ELECTRODE ARRAY EPIDURAL | $20,001 | $14,001 | — | — | 0 |
| 16206 | OCTREOTIDE,MICROSPHERES 20 MG IM SERR | $19,112 | $13,378 | — | — | 0 |
| 43293 | PANITUMUMAB 400 MG/20 ML (20 MG/ML) IV SOLN | $19,049 | $13,334 | — | — | 0 |
| 30653 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) IV SOLN | $18,749 | $13,124 | — | — | 0 |
| 11021 | RABIES IMMUNE GLOBULIN (PF) 300 UNIT/ML IM SOLN | $17,892 | $12,524 | — | — | 0 |
| 35727 | PEGFILGRASTIM (NEULASTA) 6 MG/0.6ML SUBQ SYRG | $17,714 | $12,400 | — | — | 0 |
| 41109 | CABAZITAXEL 10 MG/ML (FINAL) IV SOLN | $17,291 | $12,104 | — | — | 0 |
| 11439 | TRASTUZUMAB 150 MG IV SOLR | $17,205 | $12,044 | — | — | 0 |
| 8690 | LANREOTIDE 60 MG/0.2 ML SUBQ SYRG | $16,803 | $11,762 | — | — | 0 |
| 46555 | HC IV INFUSION PEMIVIBART | $15,939 | $11,157 | — | — | 0 |
| 46561 | HC IV INFUSION PEMIVIBART | $15,939 | $11,157 | — | — | 0 |
| 45000385 | HC OPEN TX TRIMALLEOLAR ANKLE FX INCL INT FIXATION MEDIAL/ LATERAL MALLEOLUS W/O FIXATION POST LIP | $15,916 | $11,141 | — | — | 0 |
| 67227 | CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X 2) SUBQ SYKT | $15,785 | $11,050 | — | — | 0 |
Showing top 50 of 15,681 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.